BioCentury
ARTICLE | Company News

Inflazyme, Hoechst Marion Roussel Inc. deal

May 17, 1999 7:00 AM UTC

The companies finalized their previously announced letter of intent to develop compounds to treat allergies, asthma and respiratory diseases using compounds from IZP's IPL576 class of small molecules ...